Roche announces results from Evrysdi study in infants with Type 1 spinal muscular atrophy (SMA) published in NEJM
Roche announced that the New England Journal of Medicine has published Evrysdi (risdiplam) data from the dose finding Part 1 of the pivotal FIREFISH study in infants with… read more.
